Coherus Oncology (CHRS) Other Working Capital Changes (2013 - 2026)
Coherus Oncology recorded quarterly Other Working Capital Changes of -$4.5 million in Q1 2026, down 293.9% quarter-over-quarter from $2.3 million in Q4 2025, and down 622.73% year-over-year from $858000.0 in Q1 2025.
Coherus Oncology's Other Working Capital Changes history runs 14 years deep, the most recent figure standing at -$4.5 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 622.73% year-over-year to -$4.5 million; the TTM figure through Mar 2026 stood at -$15.7 million (down 509.27% YoY), while the FY2025 annual figure was -$10.3 million, down 12695.12% from the prior year.
- Other Working Capital Changes came in at -$4.5 million for Q1 2026 at Coherus Oncology, down from $2.3 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $7.7 million in Q2 2024 to a low of -$13.5 million in Q3 2025.
- A 5-year average of -$737882.4 and a median of -$1.4 million in 2022 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes surged 553.63% in 2023 and sank 2744.21% in 2025, its largest moves.
- Coherus Oncology's Other Working Capital Changes stood at -$2.8 million in 2022, then gained by 23.54% to -$2.1 million in 2023, then sank by 100.67% to -$4.2 million in 2024, then jumped by 154.76% to $2.3 million in 2025, then sank by 293.9% to -$4.5 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$4.5 million, $2.3 million, and -$13.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Coherus Oncology | 216.87 Mn | 49.83 Mn | 8.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.49 Mn |
| Mar 31, 2026 | -4.49 Mn |
| Dec 31, 2025 | 2.31 Mn |
| Dec 31, 2025 | 2.31 Mn |
| Sep 30, 2025 | -13.51 Mn |
| Sep 30, 2025 | -13.51 Mn |
| Jun 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 858,000.00 |
| Mar 31, 2025 | 858,000.00 |
| Dec 31, 2024 | -4.22 Mn |
| Dec 31, 2024 | -4.22 Mn |
| Sep 30, 2024 | -475,000.00 |
| Sep 30, 2024 | -475,000.00 |
| Jun 30, 2024 | 7.67 Mn |
| Jun 30, 2024 | 7.67 Mn |
| Mar 31, 2024 | -2.89 Mn |
| Mar 31, 2024 | -2.89 Mn |
| Dec 31, 2023 | -2.11 Mn |
| Dec 31, 2023 | -2.11 Mn |
| Sep 30, 2023 | 4.86 Mn |
| Sep 30, 2023 | 4.86 Mn |
| Jun 30, 2023 | -2.92 Mn |
| Jun 30, 2023 | -2.92 Mn |
| Mar 31, 2023 | -1.86 Mn |
| Mar 31, 2023 | -1.86 Mn |
| Dec 31, 2022 | -2.75 Mn |
| Dec 31, 2022 | -2.75 Mn |
| Sep 30, 2022 | 744,000.00 |
| Sep 30, 2022 | 744,000.00 |
| Jun 30, 2022 | -1.41 Mn |
| Jun 30, 2022 | -1.41 Mn |
| Mar 31, 2022 | 7.63 Mn |
| Mar 31, 2022 | 7.63 Mn |
| Dec 31, 2021 | -8.42 Mn |
| Dec 31, 2021 | -8.42 Mn |
| Sep 30, 2021 | 1.03 Mn |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 5.67 Mn |
| Jun 30, 2021 | 5.67 Mn |
| Mar 31, 2021 | -2.11 Mn |
| Mar 31, 2021 | -2.11 Mn |
| Dec 31, 2020 | -2.50 Mn |
| Dec 31, 2020 | -2.50 Mn |
| Sep 30, 2020 | 7.77 Mn |
| Sep 30, 2020 | 7.77 Mn |
| Jun 30, 2020 | 2.48 Mn |
| Jun 30, 2020 | 2.48 Mn |
| Mar 31, 2020 | 3.10 Mn |
| Mar 31, 2020 | 3.10 Mn |
| Dec 31, 2019 | 3.20 Mn |
| Dec 31, 2019 | 3.20 Mn |
| Sep 30, 2019 | -1.37 Mn |
| Sep 30, 2019 | -1.37 Mn |
| Jun 30, 2019 | -1.13 Mn |
| Jun 30, 2019 | -1.13 Mn |
| Mar 31, 2019 | -30,000.00 |
| Mar 31, 2019 | -30,000.00 |
| Dec 31, 2018 | -108,000.00 |
| Dec 31, 2018 | -108,000.00 |
| Sep 30, 2018 | 573,000.00 |
| Sep 30, 2018 | 573,000.00 |
| Jun 30, 2018 | -178,000.00 |
| Jun 30, 2018 | -178,000.00 |
| Mar 31, 2018 | -715,000.00 |
| Mar 31, 2018 | -715,000.00 |
| Dec 31, 2017 | 6.24 Mn |
| Dec 31, 2017 | 6.24 Mn |
| Sep 30, 2017 | -2.12 Mn |
| Sep 30, 2017 | -2.12 Mn |
| Jun 30, 2017 | -4.80 Mn |
| Jun 30, 2017 | -4.80 Mn |
| Mar 31, 2017 | 923,000.00 |
| Mar 31, 2017 | 923,000.00 |
| Dec 31, 2016 | -19.26 Mn |
| Dec 31, 2016 | -19.26 Mn |
| Sep 30, 2016 | 3.68 Mn |
| Sep 30, 2016 | 3.68 Mn |
| Jun 30, 2016 | -3.61 Mn |
| Jun 30, 2016 | -3.61 Mn |
| Mar 31, 2016 | -58,000.00 |
| Mar 31, 2016 | -58,000.00 |
| Dec 31, 2015 | 14.67 Mn |
| Dec 31, 2015 | 14.67 Mn |
| Sep 30, 2015 | -6.85 Mn |
| Sep 30, 2015 | -6.85 Mn |
| Jun 30, 2015 | 6.48 Mn |
| Jun 30, 2015 | 6.48 Mn |
| Mar 31, 2015 | -13,000.00 |
| Mar 31, 2015 | -13,000.00 |
| Dec 31, 2014 | 1.74 Mn |
| Dec 31, 2014 | 1.74 Mn |
| Sep 30, 2014 | -4,000.00 |
| Sep 30, 2014 | -4,000.00 |
| Jun 30, 2014 | -9.07 Mn |
| Jun 30, 2014 | -9.07 Mn |
| Mar 31, 2014 | 9.39 Mn |
| Mar 31, 2014 | 9.39 Mn |
| Dec 31, 2013 | 11.27 Mn |
| Dec 31, 2013 | 11.27 Mn |